Driving force in drug development
Portugal’s best teams in science and clinics have joined forces to provide cutting-edge, customized solutions in drug development for academia and industry
Previous Work
Applying CellectAB technology to generate antibodies against CD3
Alginate Hydrogels for Medical Applications
Developing a xenograft mouse model of canine diffuse large B-cell lymphoma (DLBCL)
Process Development of Bacteriophages for application in Diagnostic Kits for the Food Industry
Assay development for the evaluationof antiviral COVID-19 surface coatings
Investigating the potential of new therapeutic strategies relevant for the treatment of glaucoma
news & announcements
Short Interview with Francisco Ambrósio
Short Interview with Francisco Ambrósio We have interviewed Francisco Ambrósio, Director of the Coimbra Institute for Clinical and Biomedical Research (iCBR) at Faculty of Medicine
A new decade, a new framework for European funding
A new decade. A new framework for European Funding In recent times, no other year has been as challenging as 2020. The turn of the
contact us
Vector B2B
Drug Developing – Associação para Investigação em Biotecnologia
Address
Avenida Professor Gama Pinto nº.2
Alameda da Universidade,
Cidade Universitária
1649-003 Lisboa
E-mail
info@vectorb2b.com
